Advanced

AJNR - American Journal of Neuroradiology

Published ahead of print on January 9, 2008
doi: 10.3174/ajnr.A0912

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: ajnr.A0912v1 29/4/798    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Wang, Z.J. Articles by Barkovich, A.J. Search for Related Content PubMed PubMed Citation Articles by Wang, Z.J. Articles by Barkovich, A.J.

American Journal of Neuroradiology 29:798-801, April 2008
© 2008 American Society of Neuroradiology

PEDIATRICS

Brain Metabolite Levels Assessed by Lactate-Edited MR Spectroscopy in Premature Neonates with and without Pentobarbital Sedation

Z.J. Wang^a, D.B. Vigneron^a, S.P. Miller^a,b, P. Mukherjee^a, N.N. Charlton^a, Y. Lu^a and A.J. Barkovich^a,b,c

^a Department of Radiology, University of California San Francisco, San Francisco, Calif
^b Department of Pediatrics, University of California San Francisco, San Francisco, Calif
^c Department of Neurology, University of California San Francisco, San Francisco, Calif

Please address correspondence to Zhen J. Wang, University of California San Francisco, Box 0628, 505 Parnassus Ave, San Francisco, CA 94143-0628; e-mail: jane.wang{at}radiology.ucsf.edu

BACKGROUND AND PURPOSE: Pentobarbital is known to affect cerebral metabolism; pentobarbital sedation is, however, frequently used for MR imaging and MR spectroscopy, especially in children. Accurate assessment of the brain metabolite levels is important, particularly in neonates with suspected brain injury. We investigated whether pentobarbital sedation has any effect on the ratios of spectral metabolites lactate, N-acetylaspartate, or choline in a group of premature neonates.

MATERIALS AND METHODS: MR spectroscopy was performed in 43 premature neonates, all with normal concurrent MR imaging and normal neurodevelopmental outcome at 12 months of age. Of those neonates, 14 (33%) required pentobarbital (Nembutal 1 mg/kg) sedation during MR spectroscopy; the remaining 29 neonates did not receive any sedation. Ratios of lactate, choline, and N-acetylaspartate were calculated in the basal ganglia, thalami, and corticospinal tracts and compared between those neonates with and without sedation.

RESULTS: Small amounts of brain lactate were detected in all of the premature neonates. The basal ganglia lactate/choline and lactate/N-acetylaspartate ratios were significantly lower, by 17% and 25% respectively, in the neonates with pentobarbital sedation compared with the age-matched neonates without sedation (P < .05). Sedation did not affect the lactate level in the thalami or the corticospinal tracts. The N-acetylaspartate/choline ratios were unaffected by pentobarbital sedation.

CONCLUSION: Pentobarbital sedation is associated with lower lactate/choline and lactate/N-acetylaspartate ratios in the basal ganglia of premature neonates, as determined by proton MR spectroscopy. Investigators should be aware of this phenomenon for accurate interpretation of their MR spectroscopy results.